Log In
Print
BCIQ
Print
Print this Print this
 

S-555739

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionProstaglandin D2 (PGD2) receptor (CRTH2; GPR44; CD294) antagonist
Molecular Target Prostaglandin D2 (PGD2) receptor (CRTH2) (GPR44) (CD294)
Mechanism of ActionProstaglandin D2 (PGD2) receptor (CRTH2) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAllergy
Indication DetailsTreat allergic disease; Treat allergic rhinitis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today